Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Male and female recipients of all races, ≥18 years of age.
• Patients undergoing primary or subsequent living or deceased donor liver transplantation.
• Subject and/or guardian must be able to provide informed consent.
• Subject and/or guardian must be able to comply with the study protocol.
Locations
United States
Illinois
Northwestern Memorial Hospital
RECRUITING
Chicago
Contact Information
Primary
Misael Villegas, BA
misael.villegas@northwestern.edu
Time Frame
Start Date: 2010-04
Estimated Completion Date: 2028-12
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Collaborators: The Scripps Research Institute
Leads: Northwestern University